search
Back to results

Cerclage for Twins With Short Cervical Length ≤ 15mm (TWIN-UIC)

Primary Purpose

Twin Pregnancy With Antenatal Problem, Preterm Birth, Short Cervix

Status
Recruiting
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Cervical cerclage
Sponsored by
Thomas Jefferson University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Twin Pregnancy With Antenatal Problem

Eligibility Criteria

18 Years - 60 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  1. Pregnant women more than 18 years of age (limits the participants to female gender)
  2. Diamniotic twin pregnancy
  3. Asymptomatic
  4. Transvaginal cervical length ≤ 15 mm between 16-23 6/7 weeks gestation

Exclusion Criteria:

  1. Singleton or higher order than twins multiple gestation
  2. Transvaginal cervical length >15mm
  3. Cervical dilation with visible amniotic membranes
  4. Amniotic membranes prolapsed into the vagina
  5. Fetal reduction after 14 weeks form higher order
  6. Monoamniotic twins
  7. Twin-twin transfusion syndrome
  8. Ruptured membranes
  9. Major fetal structural anomaly
  10. Fetal chromosomal abnormality
  11. Cerclage already in place for other indication
  12. Active vaginal bleeding
  13. Clinical chorioamnionitis
  14. Placenta previa
  15. Painful regular uterine contractions
  16. Labor

Sites / Locations

  • George Washington University
  • Thomas Jefferson University HospitalRecruiting
  • Austin Maternal Fetal Medicine St David's Health CareRecruiting
  • The Egyptian IVF CenterRecruiting
  • Bologna UniversityRecruiting
  • University of BresciaRecruiting
  • Università degli Studi di Napoli "Federico II"Recruiting
  • University of BarcelonaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

No Intervention

Arm Label

Cervical cerclage + vaginal progesterone

Vaginal progesterone

Arm Description

Cervical cerclage in twin pregnancy with transvaginal cervical length ≤15mm and Daily vaginal progesterone 400mg from diagnosis of short cervix to 36 weeks

Daily vaginal progesterone 400mg from diagnosis of short cervix to 36 weeks

Outcomes

Primary Outcome Measures

Preterm delivery less than 34 weeks
Incidence of preterm birth less than 34 weeks (any indication)

Secondary Outcome Measures

Spontaneous preterm birth rates
Incidence of spontaneous preterm birth less than 34 weeks
Preterm delivery less than <32 weeks, <28 weeks, or <24 weeks
Incidence of preterm birth less than <32 weeks, <28 weeks, or <24 weeks
Mean gestational age at delivery
Mean value of gestational age at delivery (weeks)
Birth weight at birth
Mean value (grams)
Gestational age at spontaneous rupture of membranes
Mean value (weeks) through study completion
Premature rupture of membranes
Incidence
Chorioamnionitis
Incidence
Composite adverse neonatal outcome
Includes necrotizing enterocolitis, intraventricular hemorrhage (grade 3 or higher), respiratory distress syndrome, bronchopulmonary dysplasia, retinopathy, blood-culture proven sepsis
Neonatal death
Incidence
Maternal death
Incidence
Interval between diagnosis and delivery
Mean value (days) through study completion

Full Information

First Posted
November 8, 2017
Last Updated
April 23, 2020
Sponsor
Thomas Jefferson University
Collaborators
Federico II University
search

1. Study Identification

Unique Protocol Identification Number
NCT03340688
Brief Title
Cerclage for Twins With Short Cervical Length ≤ 15mm
Acronym
TWIN-UIC
Official Title
Cervical Cerclage for Preventing Spontaneous Preterm Birth in Twin Pregnancies With Transvaginal Ultrasound Cervical Length ≤ 15mm: a Study Protocol for a Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2020
Overall Recruitment Status
Recruiting
Study Start Date
June 22, 2017 (Actual)
Primary Completion Date
June 2024 (Anticipated)
Study Completion Date
June 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Thomas Jefferson University
Collaborators
Federico II University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a multicenter randomized study designed to determine if ultrasound indicated cerclage reduces the incidence of spontaneous preterm birth <34 weeks in asymptomatic women with twin gestations and cervical length ≤15mm, diagnosed by transvaginal ultrasound between 16 to 23 6/7 weeks of gestation.
Detailed Description
Twin pregnancies have 59% incidence of preterm delivery (before 37 weeks of gestation), with increased perinatal mortality and neonatal morbidity. No therapy has proven effective in preventing preterm birth in twins. The transvaginal cervical length (TVCL) performed before 24 weeks have been determined to be the best tool to identified women with twin pregnancy at risk of preterm birth (PTB). When short TVCL is identified before 24 weeks, the risk of preterm birth is 60%-70% for TVCL ≤25mm and 80%-90% for TVCL ≤15mm. There are a small number of case reports of cervical cerclage in twin pregnancies with cervical length ≤15mm that suggest decreased preterm birth by 80%. The investigators' objective is to determine if ultrasound indicated cerclage in reduces the incidence of spontaneous preterm birth <34 weeks and improve perinatal outcome in asymptomatic women with twin gestations and cervical length ≤15mm between 16 to 23 6/7 weeks of gestation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Twin Pregnancy With Antenatal Problem, Preterm Birth, Short Cervix

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Cervical cerclage + vaginal progesterone
Arm Type
Active Comparator
Arm Description
Cervical cerclage in twin pregnancy with transvaginal cervical length ≤15mm and Daily vaginal progesterone 400mg from diagnosis of short cervix to 36 weeks
Arm Title
Vaginal progesterone
Arm Type
No Intervention
Arm Description
Daily vaginal progesterone 400mg from diagnosis of short cervix to 36 weeks
Intervention Type
Procedure
Intervention Name(s)
Cervical cerclage
Intervention Description
Cervical cerclage indicated by short cervix ≤15mm
Primary Outcome Measure Information:
Title
Preterm delivery less than 34 weeks
Description
Incidence of preterm birth less than 34 weeks (any indication)
Time Frame
at delivery
Secondary Outcome Measure Information:
Title
Spontaneous preterm birth rates
Description
Incidence of spontaneous preterm birth less than 34 weeks
Time Frame
at delivery
Title
Preterm delivery less than <32 weeks, <28 weeks, or <24 weeks
Description
Incidence of preterm birth less than <32 weeks, <28 weeks, or <24 weeks
Time Frame
at delivery
Title
Mean gestational age at delivery
Description
Mean value of gestational age at delivery (weeks)
Time Frame
at delivery
Title
Birth weight at birth
Description
Mean value (grams)
Time Frame
at delivery
Title
Gestational age at spontaneous rupture of membranes
Description
Mean value (weeks) through study completion
Time Frame
at delivery
Title
Premature rupture of membranes
Description
Incidence
Time Frame
at delivery
Title
Chorioamnionitis
Description
Incidence
Time Frame
at delivery
Title
Composite adverse neonatal outcome
Description
Includes necrotizing enterocolitis, intraventricular hemorrhage (grade 3 or higher), respiratory distress syndrome, bronchopulmonary dysplasia, retinopathy, blood-culture proven sepsis
Time Frame
Incidence between birth and 28 days of age
Title
Neonatal death
Description
Incidence
Time Frame
Between birth and 28 days of age
Title
Maternal death
Description
Incidence
Time Frame
Between birth and 6 weeks postpartum
Title
Interval between diagnosis and delivery
Description
Mean value (days) through study completion
Time Frame
at delivery

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
Only pregnant women
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Pregnant women more than 18 years of age (limits the participants to female gender) Diamniotic twin pregnancy Asymptomatic Transvaginal cervical length ≤ 15 mm between 16-23 6/7 weeks gestation Exclusion Criteria: Singleton or higher order than twins multiple gestation Transvaginal cervical length >15mm Cervical dilation with visible amniotic membranes Amniotic membranes prolapsed into the vagina Fetal reduction after 14 weeks form higher order Monoamniotic twins Twin-twin transfusion syndrome Ruptured membranes Major fetal structural anomaly Fetal chromosomal abnormality Cerclage already in place for other indication Active vaginal bleeding Clinical chorioamnionitis Placenta previa Painful regular uterine contractions Labor
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Amanda Roman, MD
Phone
215.955.9200
Email
amanda.roman@jefferson.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Amanda Roman, MD
Organizational Affiliation
Thomas Jefferson University
Official's Role
Principal Investigator
Facility Information:
Facility Name
George Washington University
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20052
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alexis Gimovsky, MD
Email
agimovsky@gmail.com
Facility Name
Thomas Jefferson University Hospital
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19107
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Amanda Roman, MD
Phone
215-955-9200
Email
amanda.roman@jefferson.edu
First Name & Middle Initial & Last Name & Degree
MD
Facility Name
Austin Maternal Fetal Medicine St David's Health Care
City
Austin
State/Province
Texas
ZIP/Postal Code
78758
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sina Haeri, MD
Email
sinahaeri@gmail.com
Facility Name
The Egyptian IVF Center
City
Cairo
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mona Aboulghar, MD
Email
monaaboulghar71@gmail.com
First Name & Middle Initial & Last Name & Degree
Yahia EL faissal, MD
Email
yahiaelfaissal@gmail.com
Facility Name
Bologna University
City
Bologna
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Giuliana Simonazzi, MD
Email
giuliana.simonazzi@unibo.it
First Name & Middle Initial & Last Name & Degree
Nicola Rizzo
Email
nicola.rizzo@unibo.it
Facility Name
University of Brescia
City
Brescia
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anna Fichera, MD
Email
anna.fichera@gmail.com
First Name & Middle Initial & Last Name & Degree
Federico Prefumo, MD
Email
federico.prefumo@gmail.com
Facility Name
Università degli Studi di Napoli "Federico II"
City
Naples
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gabriele Saccone, MD
Email
gabriele.saccone@libero.it
First Name & Middle Initial & Last Name & Degree
Pasquale Martinelli, MD
Email
martinel@unina.it
Facility Name
University of Barcelona
City
Barcelona
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Núria Baños, MD
Email
NBANOS@clinic.cat

12. IPD Sharing Statement

Plan to Share IPD
Yes
Citations:
PubMed Identifier
23400611
Citation
Hamilton BE, Hoyert DL, Martin JA, Strobino DM, Guyer B. Annual summary of vital statistics: 2010-2011. Pediatrics. 2013 Mar;131(3):548-58. doi: 10.1542/peds.2012-3769. Epub 2013 Feb 11.
Results Reference
result
PubMed Identifier
8885774
Citation
Goldenberg RL, Iams JD, Miodovnik M, Van Dorsten JP, Thurnau G, Bottoms S, Mercer BM, Meis PJ, Moawad AH, Das A, Caritis SN, McNellis D. The preterm prediction study: risk factors in twin gestations. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 1996 Oct;175(4 Pt 1):1047-53. doi: 10.1016/s0002-9378(96)80051-2.
Results Reference
result
PubMed Identifier
20576253
Citation
Conde-Agudelo A, Romero R, Hassan SS, Yeo L. Transvaginal sonographic cervical length for the prediction of spontaneous preterm birth in twin pregnancies: a systematic review and metaanalysis. Am J Obstet Gynecol. 2010 Aug;203(2):128.e1-12. doi: 10.1016/j.ajog.2010.02.064. Epub 2010 Jun 23.
Results Reference
result
PubMed Identifier
25644964
Citation
Saccone G, Rust O, Althuisius S, Roman A, Berghella V. Cerclage for short cervix in twin pregnancies: systematic review and meta-analysis of randomized trials using individual patient-level data. Acta Obstet Gynecol Scand. 2015 Apr;94(4):352-8. doi: 10.1111/aogs.12600. Epub 2015 Mar 1.
Results Reference
result
PubMed Identifier
25637840
Citation
Roman A, Rochelson B, Fox NS, Hoffman M, Berghella V, Patel V, Calluzzo I, Saccone G, Fleischer A. Efficacy of ultrasound-indicated cerclage in twin pregnancies. Am J Obstet Gynecol. 2015 Jun;212(6):788.e1-6. doi: 10.1016/j.ajog.2015.01.031. Epub 2015 Jan 28.
Results Reference
result
PubMed Identifier
28067007
Citation
Romero R, Conde-Agudelo A, El-Refaie W, Rode L, Brizot ML, Cetingoz E, Serra V, Da Fonseca E, Abdelhafez MS, Tabor A, Perales A, Hassan SS, Nicolaides KH. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data. Ultrasound Obstet Gynecol. 2017 Mar;49(3):303-314. doi: 10.1002/uog.17397.
Results Reference
result

Learn more about this trial

Cerclage for Twins With Short Cervical Length ≤ 15mm

We'll reach out to this number within 24 hrs